SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors

BACKGROUND: Convalescent plasma therapy is a leading treatment for conferring temporary immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. However, not all recovered patients develop adequate antibody titers for donation and the relationship between avidity and neu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Benner, Sarah E, Patel, Eshan U, Laeyendecker, Oliver, Pekosz, Andrew, Littlefield, Kirsten, Eby, Yolanda, Fernandez, Reinaldo E, Miller, Jernelle, Kirby, Charles S, Keruly, Morgan, Klock, Ethan, Baker, Owen R, Schmidt, Haley A, Shrestha, Ruchee, Burgess, Imani, Bonny, Tania S, Clarke, William, Caturegli, Patrizio, Sullivan, David, Shoham, Shmuel, Quinn, Thomas C, Bloch, Evan M, Casadevall, Arturo, Tobian, Aaron A R, Redd, Andrew D
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7499592/
https://ncbi.nlm.nih.gov/pubmed/32910175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiaa581
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados